HomeCompareCDMO vs DIVO

CDMO vs DIVO: Dividend Comparison 2026

CDMO yields 16.01% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIVO wins by $8.4K in total portfolio value· pulled ahead in Year 2
10 years
CDMO
CDMO
● Live price
16.01%
Share price
$12.49
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.6K
Annual income
$1.79
Full CDMO calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — CDMO vs DIVO

📍 DIVO pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDMODIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDMO + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDMO pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDMO
Annual income on $10K today (after 15% tax)
$1,361.09/yr
After 10yr DRIP, annual income (after tax)
$1.52/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, DIVO beats the other by $855.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDMO + DIVO for your $10,000?

CDMO: 50%DIVO: 50%
100% DIVO50/50100% CDMO
Portfolio after 10yr
$26.8K
Annual income
$505.14/yr
Blended yield
1.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CDMO right now

CDMO
Analyst Ratings
1
Strong
8
Buy
1
Hold
Consensus: Buy
Price Target
$8.00
-35.9% upside vs current
Range: $8.00 — $8.00
Altman Z
-0.6
Piotroski
3/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDMO buys
0
DIVO buys
0
No recent congressional trades found for CDMO or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDMODIVO
Forward yield16.01%6.62%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$22.6K$31.0K
Annual income after 10y$1.79$1,008.47
Total dividends collected$1.7K$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CDMO vs DIVO ($10,000, DRIP)

YearCDMO PortfolioCDMO Income/yrDIVO PortfolioDIVO Income/yrGap
1$11,501$800.64$11,362$661.96+$139.00CDMO
2← crossover$12,736$430.27$12,860$702.91$124.00DIVO
3$13,850$222.66$14,504$743.56$654.00DIVO
4$14,933$113.15$16,303$783.73$1.4KDIVO
5$16,035$57.01$18,268$823.31$2.2KDIVO
6$17,186$28.60$20,408$862.17$3.2KDIVO
7$18,404$14.33$22,737$900.20$4.3KDIVO
8$19,699$7.17$25,266$937.31$5.6KDIVO
9$21,081$3.59$28,008$973.42$6.9KDIVO
10$22,559$1.79$30,977$1,008.47$8.4KDIVO

CDMO vs DIVO: Complete Analysis 2026

CDMOStock

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Full CDMO Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this CDMO vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDMO vs SCHDCDMO vs JEPICDMO vs OCDMO vs KOCDMO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.